COVID-19 Resources

NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific institutional responses may be helpful to others. Therefore, we are expeditiously providing documents and recommendations developed by NCCN Member Institutions or Guideline Panels as resources for oncology care providers.  These resources have not been developed or reviewed by the standard NCCN processes, and are provided for informational purposes only. We will post more resources as they become available. Please check back for additional updates.


COVID-19 Vaccination and Cancer Patients

NCCN has recently formed a COVID-19 Vaccine Committee including top hematology and oncology experts with particular expertise in infectious diseases, vaccination development, medical ethics, and health information technology. This committee has established recommendations that can help cancer care providers make informed decisions on how to protect their patients from the ongoing COVID-19 pandemic, based on available evidence plus expert consensus. This information is being continually updated as more vaccine options become available.

Download Recommendations


Any submissions related to the vaccination recommendations are reviewed by the NCCN Covid-19 Vaccination Advisory Committee.

Submission by Janssen Pharmaceutical Companies of Johnson & Johnson on 04/09/2021


Cancer Won't Wait And Neither Should You

NCCN and ACS are teaming up with leading health organizations across the country to endorse the safe resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. A coalition of 76 organizations have signed a letter to the public about the significant threat cancer poses to people's health.

Learn More



NEW! NCCN Best Practices Webinar Series: COVID-19 and Cancer Center Operations

Utilization of Network Satellite Locations

Monday, June 7, 2021 | 4:15 – 5:30 PM EDT
Registration is free!

Hear how cancer centers utilized network satellite locations during the pandemic, including key lessons learned, major accomplishments, continued challenges, and essential next steps. Dr. Ephraim Hochberg and Beth Souza, MHA from Massachusetts General Hospital Cancer Center, and Dr. Lawrence Shulman from Abramson Cancer Center at the University of Pennsylvania will share center strategies, plans for the future, and take questions from the audience. The session will be moderated by NCCN Best Practices Committee Co-Chair Theresa Franco, MSN, RN from Fred & Pamela Buffett Cancer Center.

Register Now


Telemedicine in Oncology and Payer Policies
Monday, June 21, 2021 | 1:15 – 2:30 PM EDT
Registration is free!

Telemedicine use in oncology has evolved over the last year, and this discussion will focus on what we have learned and how it will impact the future of cancer care.  Dr. Anne Chiang will provide specific examples from Yale Cancer Center/Smilow Cancer Hospital and discuss optimizing telemedicine operations in oncology. Additionally, Dr. Scott Lawrence from the Centers for Medicare and Medicaid Services will provide an update on telemedicine policy and reimbursement. The speakers will also take questions from the audience. The session will be moderated by NCCN Best Practices Committee Co-Chair Dr. Tim Kubal from Moffitt Cancer Center.

Register Now    



Treatment Recommendations

      Supportive Care

      Other Resources

      NCCN Best Practices Webinar Series: Creative Strategies Implemented during COVID-19 that will Impact the Future of Cancer Care

      American Cancer Society COVID-19 and Cancer ECHO for Cancer Care Teams webinars

      American Cancer Society COVID-19 and Cancer ECHO for Cancer Caregivers webinars

      Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic

      Free program with CE credit available.